Navigation Links
Cryoport Introduces New Tamper-Proof Lock on its Cryoport Express(R) Shippers for Animal Husbandry
Date:3/18/2015

LAKE FOREST, Calif., March 18, 2015 /PRNewswire/ -- Cryoport, Inc. (OTCBB: CYRX) ("Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company introduced Vet SecureSM, a new tamper-proof lock on its Cryoport Express® Shippers for exclusive use in the global animal husbandry market.

Cryoport internally developed Vet SecureSM, a tamper-proof lock for the Company's dry vapor shippers that will be used exclusively for animal husbandry. This feature was designed to support international shipping regulations, enabling Cryoport to transport animal husbandry specimens globally. The sealed lock will prevent the removal of the vapor plug from the shipper without recognition in order to preserve the integrity of the shipped specimen.

Animal husbandry is a multi-billion dollar industry that includes the breeding of animals by humans, in which desired genetic qualities and behaviors are further developed. This practice of selectively breeding and raising animals is done to promote desirable traits in animals for utility, sport, pleasure or research.  The time and cost involved in breeding dictate the need for increased security for these global shipments.

Jerrell Shelton, Chief Executive Officer of Cryoport, commented, "I am extremely pleased with the quick turnaround time our team demonstrated in developing and implementing a tamper proof lock for the animal husbandry market. This innovative solution enables the company to provide a sure and comprehensive solution for international shipments serving the animal husbandry market.  Breeding horses and shipping warm-blooded equine semen, to give an example, is a very expensive venture for both parties involved and both parties will benefit from Vet SecureSM, our tamper-proof lock guaranteeing the trustworthiness of the specimen.  There is a huge opportunity for our best-in-class cryogenic logistics solutions to further expand our reach into the growing animal husbandry market as we continue to focus on providing an ever more comprehensive solution to our clients."

About Cryoport, Inc.

Cryoport is the premier provider of cryogenic logistics solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. We provide leading edge logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide including points-of-care, CRO's, central laboratories, pharmaceutical companies, contract manufacturers, and university researchers. Our packaging is built around our proprietary Cryoport Express® liquid nitrogen dry vapor shippers, which are validated to maintain a constant -150°C temperature for a 10 day dynamic shipment duration. Our information technology centers around our Cryoportal™ Logistics Management Platform, which facilitates management of the entire shipment process. Cryoport is the preferred cryogenic logistics solutions partner to the world's largest shipping companies controlling more than 85% of the world's air shipments. For more information, visit www.cryoport.com.

To download Cryoport's investor relations app, which offers access to SEC documents, press releases, videos, audiocasts and more, please click the following link from your iPhone and iPad or  Android mobile device.

Forward Looking Statements

Statements in this news release which are not purely historical, including statements regarding Cryoport, Inc.'s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, and technical development risks. The company's business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2013. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Cryoport, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

 


'/>"/>
SOURCE Cryoport, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Cryoport Provides Logistics Solution and Services for Kite Pharmas Lead Clinical Program in Cancer Immunotherapy
2. Cryoport and Sanaria Expand Logistics Partnership Supporting Malaria Vaccines
3. Cryoport Launches New Logistics Service Supporting Facility Relocation of Cryogenically Frozen Sample Collections
4. Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa
5. Cryoport Appoints VP of Strategic Business Development and Accelerates Expansion of Direct Sales Force
6. Cryoport Expands Sales Force to Meet Increasing Demand
7. Cryoport and DHL Partner to Provide Cryogenic Logistics Solutions for Life Sciences and Healthcare Clients
8. METTLER TOLEDO Introduces Sensors That Learn™
9. JULABO USA Introduces Virtual Set-Up Program - vDelivery™
10. Cole-Parmer Introduces Easy-To-Use Catalyst Peristaltic Pumps by Masterflex
11. PPTA Introduces New Cross Donation Check System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):